Skip to content
10-Q

Quarterly Report

GAIN THERAPEUTICS, INC GANX

0001558370-25-011220

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 35.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 30.34M sh
Shares Diluted Q2 2025 · Jun 30, 2025 29.52M sh
Shares Diluted Q2 2025 · Jun 30, 2024 19.22M sh
Shares Diluted Q2 2025 · Jun 30, 2024 18.6M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$8.92M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$9.34M
Long Term Debt Q2 2025 · Jun 30, 2025 $325.36K
Long Term Debt Q2 2025 · Dec 31, 2024 $328.33K
Short Term Debt Q2 2025 · Jun 30, 2025 $126.11K
Short Term Debt Q2 2025 · Dec 31, 2024 $110.18K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $6.69M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $10.39M
Stockholders Equity Q2 2025 · Jun 30, 2025 $3.7M
Stockholders Equity Q2 2025 · Mar 31, 2025 $5.78M
Stockholders Equity Q2 2025 · Dec 31, 2024 $7.34M
Stockholders Equity Q2 2025 · Jun 30, 2024 $11.78M
Stockholders Equity Q2 2025 · Mar 31, 2024 $8.64M
Stockholders Equity Q2 2025 · Dec 31, 2023 $12.58M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.2M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.91M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.14M
Total Liabilities Q2 2025 · Dec 31, 2024 $4.78M
Current Assets Q2 2025 · Jun 30, 2025 $9.31M
Current Assets Q2 2025 · Dec 31, 2024 $11.6M
Total Assets Q2 2025 · Jun 30, 2025 $9.83M
Total Assets Q2 2025 · Dec 31, 2024 $12.12M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.19
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.35
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.42
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.65
Eps Basic Q2 2025 · Jun 30, 2025 −$0.19
Eps Basic Q2 2025 · Jun 30, 2025 −$0.35
Eps Basic Q2 2025 · Jun 30, 2024 −$0.42
Eps Basic Q2 2025 · Jun 30, 2024 −$0.65
Sga Expense Q2 2025 · Jun 30, 2025 $2.33M
Sga Expense Q2 2025 · Jun 30, 2025 $4.44M
Sga Expense Q2 2025 · Jun 30, 2024 $3.75M
Sga Expense Q2 2025 · Jun 30, 2024 $5.62M
Rd Expense Q2 2025 · Jun 30, 2025 $2.76M
Rd Expense Q2 2025 · Jun 30, 2025 $5.02M
Rd Expense Q2 2025 · Jun 30, 2024 $4.44M
Rd Expense Q2 2025 · Jun 30, 2024 $6.94M
Net Income Q2 2025 · Jun 30, 2025 −$5.81M
Net Income Q2 2025 · Jun 30, 2025 −$10.34M
Net Income Q2 2025 · Jun 30, 2024 −$8.14M
Net Income Q2 2025 · Jun 30, 2024 −$12.16M
Operating Income Q2 2025 · Jun 30, 2025 −$5.09M
Operating Income Q2 2025 · Jun 30, 2025 −$9.46M
Operating Income Q2 2025 · Jun 30, 2024 −$8.18M
Operating Income Q2 2025 · Jun 30, 2024 −$12.56M